Activity Description
Over the course of this 1.0 credit/contact hour certified interactive live activity, an interdisciplinary faculty team including an HIV specialist, LGBTQ+ primary care clinician, and prevention services leader will examine the rationale, clinical considerations, and operational readiness required to implement same-day PrEP initiation within real-world practice settings. Faculty will discuss patient-centered approaches to assessing eligibility and readiness, integration of rapid HIV testing technologies, interpretation of baseline laboratory assessments, and practical workflow strategies that support routinized same-day PrEP delivery.
Through case-based discussion, audience polling, implementation insights, and practical tools, participants will gain actionable strategies to strengthen same-day PrEP capacity and reduce barriers to timely HIV prevention services within their own organizations and communities.
Target Audience
The target audience for this program is clinicians and allied health professionals, including primary care providers, HIV care providers, sexual health providers, pharmacists, addiction specialists, and PrEP navigation staff who are currently engaging in HIV prevention delivery.
-
Media: Enduring Material
-
Release date: June 16, 2026
-
Expiration date: June 16, 2026
-
Time to Complete: 60 minutes
Educational Objectives
After completing this activity, the participant should be better able to:
-
Evaluate the clinical rationale and public health impact of sameday PrEP initiation models in improving PrEP uptake, reducing delays in HIV prevention access, and supporting equitable delivery of prevention services.
-
Apply evidence-based strategies to assess patient eligibility, readiness, and baseline clinical considerations for same-day PrEP initiation, including integration of rapid HIV testing and laboratory evaluation.
-
Identify operational, workflow, and interdisciplinary practice strategies necessary to support implementation and routinization of same-day PrEP services within diverse healthcare settings.
Accreditation, Credit, and Support
Participants can earn up to 1.5 credits/contact hours (CME, AAPA, ANCC, CPE, ASWB) for completion of this educational activity.
In support of improving patient care, HealthHIV, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
HealthHIV designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Continuing Medical Education
Physician Associate Credit Designation Statement
HealthHIV designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour.
Continuing Pharmacy Education
HealthHIV designates this continuing education activity for 1.0 contact hour (0.1 CEU) of the Accreditation Council for Pharmacy Education.
Type of Activity: Knowledge
Please see below for UAN number assigned:
JA4008396-0000-26-032-H02-P
Social Worker Continuing Education
As a Jointly Accredited Organization, HealthHIV is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program. Regulatory boards have the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.0 general continuing education credit.
Interprofessional Continuing Education (IPCE) Statement
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.Support Statement
This program has been supported by an independent educational grant from Gilead Pharmaceuticals.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from HealthHIV, the accredited provider, have been reviewed for relevant financial relationships with ineligible companies. One planner has disclosed a relevant financial relationship, which has been mitigated in accordance with the Standards for Integrity and Independence in Accredited Continuing Education. All remaining planners and content/peer reviewers have no relevant financial relationships to disclose.
Planner Disclosure: Marissa Tonelli has disclosed the following relevant financial relationships with an ineligible company:
– Advisor, Consultant, or Independent Contractor for Gilead Pharmaceuticals
These relationships have been mitigated in accordance with the standards of Joint Accreditation for Interprofessional Continuing Education™ and the ACCME Standards for Integrity and Independence in Accredited Continuing Education.
Faculty Disclosures
Aniruddha Hazra, MD
Associate Professor of Medicine University of Chicago, and Medical Director, UCM Sexual Wellness Clinic,Chicago, IL
Disclosure: Aniruddha Hazra Has disclosed the following relevant financial relationships with ineligible companies:
– Advisor, Consultant, or Independent Contractor for Gilead Sciences and ViiV Healthcare
– Recipient of research funding from Gilead Sciences
All relevant financial relationships have been mitigated in accordance with the standards of Joint Accreditation for Interprofessional Continuing Education™ and the ACCME Standards for Integrity and Independence in Accredited Continuing Education.
Justin Hooks, DNP, FNP-BC
Family Nurse Practitioner, Corktown Health
Detroit, MI
Disclosure: Justin Hooks has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Disclosure & Conflict of Interest Policy
HealthHIV is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, HealthHIV requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to HealthHIV policy. These disclosures will be provided to learners prior to the start of the CE activity.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 80% or higher is needed to obtain credit. Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
For Pharmacists, HealthHIV will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
About This Activity
HealthHIV is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of HealthHIV.
The materials presented here are used with the permission of the authors and/or other sources.
If you have any questions related to educational credits, including the type or amount of credit awarded, reporting of credits to certifying boards, or general accreditation-related inquiries, please contact the Accreditation Team at accreditation@healthhiv.org. A member of our team will be happy to assist you.
If you are experiencing issues accessing or downloading your certificate of completion, or if you have questions specifically about your individual certificate, please reach out directly to Beth at beth@healthhiv.org.